Key result
Cinchonidine inhibits muscle differentiation by blocking IRS-1 phosphorylation, suggesting a role in inducing sarcopenia.
Why the study?
While diseases such as cardiovascular and chronic liver disease can induce sarcopenia, evidence regarding specific diseases and mechanisms responsible for its development is limited.
Does cinchonidine inhibit muscle differentiation in mouse satellite cells and myoblast cell lines?
Does cinchonidine inhibit muscle differentiation in mouse satellite cells and myoblast cell lines?
Cinchonidine, an antimalarial agent, inhibits muscle differentiation via suppression of IRS-1 phosphorylation, suggesting a potential mechanism for drug-induced sarcopenia.
Answers are grounded in this paper and cite their sources.
Does not support changing practice; hypothesis-generating for cinchonidine-induced sarcopenia and leaves open human translation.
Sarcopenia is an age-related condition marked by a reduction in muscle mass and strength, and it is associated with impaired muscle regeneration and differentiation. While diseases like cardiovascular and chronic liver disease can induce sarcopenia, there is limited evidence regarding the specific diseases and mechanisms responsible for its development. In skeletal muscle, the loss of muscle mass is accompanied by a decrease in myofilament proteins and the inhibition of muscle differentiation in satellite cells. Bioactive compounds obtained from natural products have been traditionally used as therapeutics for diverse conditions. In this report, we investigated the effect of cinchonidine (CD) extracted from Cinchona tree on muscle differentiation of mouse satellite cells, and myoblast cell lines. CD significantly inhibited muscle differentiation by suppressing myotube formation and gene expression of myogenesis markers. In addition, CD reduced muscle differentiation by blocking phosphorylation of insulin receptor substrate 1 (IRS-1) during insulin-induced signal transduction. Therefore, the results show that CD, an antimalarial agent, inhibited muscle differentiation through the suppression of IRS-1 phosphorylation, suggesting that sarcopenia can be induced by CD.
No takes yet. Share an insight, caveat, or question.
Byun et al. (2025) studied this question. Cinchonidine inhibited muscle differentiation by blocking IRS-1 phosphorylation, suggesting its role in inducing sarcopenia.
Synapse has enriched 10 related papers. Consider them for comparative context: